41682 Federal Register / Vol. 65, No. 130 / Thursday, July 6, 2000 / Notices

Form Number of respondents

Responses

per respondent

Hours per responseTotal hour burden

SDS .................................................................................................................. 450 1 25.5 11,475

Total .......................................................................................................... 450 ........................ ........................ 11,475

Send comments to Susan G. Queen,

Ph.D., HRSA Reports Clearance Officer,

Room 14–33, Parklawn Building, 5600

Fishers Lane, Rockville, MD 20857.

Written comments should be received

within 60 days of this notice.

Dated: June 29, 2000.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–16973 Filed 7–5–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the meeting of the

Board of Scientific Counselors, National

Cancer Institute.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in sections

552b(c)(6) and 552b(c)(9)(B), title 5

U.S.C., as amended. The discussions

could reveal information of a personal

nature where disclosure would

constitute a clearly unwarranted

invasion of personal privacy and the

premature disclosure of discussions

related to personnel and programmatic

issues would be likely to significantly

frustrate the subsequent implementation

of recommendations.

Name of Committee: Board of Scientific

Counselors, National Cancer Institute,

Subcommittee A—Clinical Sciences and

Epidemiology.

Date: July 24, 2000.

Time: 8:30 a.m. to 4:00 p.m.

Agenda: Discussion of personnel and

programmatic issues and Review and

evaluate individual Principal Investigators.

Place: National Cancer Institute, Building

31, C Wing, 6th floor, Conference Room 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Abby Sandler, Executive

Secretary, Institute Review Office, Office of

the Director, National Cancer Institute,

National Institutes of Health, 6116 Executive

Boulevard, Room 7019, Bethesda, MD 20892,

(301) 496–7628.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower, 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 29, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–17096 Filed 7–5–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meeting. The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel Program

Projects.

Date: August 4, 2000.

Time: 8:30 a.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Key Bridge Marriott, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Rita Liu, Health Scientist

Administrator, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2620.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: June 29, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–17097 Filed 7–5–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel Phase II

SBIR: ‘‘Prevention Activities Handbook: A

Practioner’s Guide to Selecting and

Implementing Interactive Drug Use

Prevention Activities for Children and

Adolescents’’.

Date: July 18, 2000.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1438.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Clinical Trial Network Administrative

Coordinating Center’’.

Date: July 25–26, 2000.

Time: 9 a.m. to 5 p.m.